R’Kes Starling, RPh, MBA
Chief Executive Officer/President
Reveles Inc.
R’Kes D. Starling is a healthcare executive and trained pharmacist with nearly 25 years of experience advancing clinical research, specialty pharmacy, and commercialization strategy. He is a two-term member of the Board of Trustees for the Association of Clinical Research Professionals (ACRP), where he champions initiatives focused on research quality, decentralized clinical trials, and inclusive participation. As the Founder/CEO of Reveles Inc., R’Kes led the development of an AI-powered engagement platform and collaborated with over 45 biopharmaceutical companies to accelerate trial access and diversity. Previously, he served as Vice President at McKesson Corporation, leading a $250M oncology-focused specialty pharmacy and clinical research division in partnership with the US Oncology Network. With deep therapeutic expertise in oncology, nephrology, and immunology, R’Kes has built high-performing teams and scalable solutions to bring life-changing therapies to market while ensuring that underrepresented communities are meaningfully included in research.